NCT06723366View on ClinicalTrials.gov

Protective Effect of Angong Niuhuang Against Negative Inflammatory Response and Neurologic Dysfunction After Cardiovascular Surgery

NANot yet recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Cardio-pulmonary BypassCardiovascular SurgeryCerebral ProtectionBrain Injury
Interventions
DRUG

Angong Niuhuang Pill (ANP)

Angong Niuhuang Pill (ANP) (3 g/pill, 1 pill/day for 5 days)

OTHER

Control (Standard treatment)

Blank control

Trial Locations (2)

210029

The First Affiliated Hospital of Nanjing Medical University, Nanjing

Unknown

Beijing Anzhen Hospital, Capital Medical University, Beijing

Sponsors
All Listed Sponsors
collaborator

The First Affiliated Hospital with Nanjing Medical University

OTHER

collaborator

Beijing Anzhen Hospital

OTHER

lead

Nanjing Medical University

OTHER